v3.26.3
Financial Instruments - Narrative (Details) - USD ($)
3 Months Ended 4 Months Ended 9 Months Ended
May 18, 2026
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Realized investment gains (losses)   $ 0 $ 0   $ 0 $ 0
Change in fair value of contingent consideration         13,738,000 $ 2,390,000
Endospan            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Contingent consideration $ 21,782,000          
Change in fair value of contingent consideration       $ (4,400,000)    
Business combination, contingent consideration, liability   $ 24,700,000   $ 24,700,000 24,700,000  
Endospan | Initially Recognized            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Contingent consideration 26,200,000          
Endospan | After Measurement Period Adjustments            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Contingent consideration $ 21,800,000          
Endospan | Level 3            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Change in fair value of contingent consideration         2,898,000  
Endospan | Level 3 | After Measurement Period Adjustments            
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]            
Contingent consideration         $ 21,800,000